5670-23-5 Usage
General Description
4-methylbenzofuran, also known as 2,3-dihydro-4-methylbenzofuran, is a chemical compound with a molecular formula C9H8O. It is a colorless liquid with a distinctive sweet odor, and it is commonly used as a flavor and fragrance ingredient in the food and cosmetic industries. 4-methylbenzofuran can be found in natural sources such as essential oils and is also used as a synthetic intermediate in the production of pharmaceuticals and other organic compounds. It is considered to be relatively stable under normal conditions but may react violently with oxidizing agents. The compound's potential environmental impacts and health effects are not well documented, so it requires careful handling and disposal to minimize any potential risks.
Check Digit Verification of cas no
The CAS Registry Mumber 5670-23-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,6,7 and 0 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 5670-23:
(6*5)+(5*6)+(4*7)+(3*0)+(2*2)+(1*3)=95
95 % 10 = 5
So 5670-23-5 is a valid CAS Registry Number.
InChI:InChI=1/C9H8O/c1-7-3-2-4-9-8(7)5-6-10-9/h2-6H,1H3
5670-23-5Relevant articles and documents
Dioxazolones as masked ester surrogates in the Pd(ii)-catalyzed direct C-H arylation of 6,5-fused heterocycles
Saxena, Paridhi,Maida, Neha,Kapur, Manmohan
supporting information, p. 11187 - 11190 (2019/09/30)
A simple and effective Pd(ii)-catalyzed regioselective C(2)-H arylation of 6,5-fused heterocycles with dioxazolones as a masked ester surrogate under mild conditions is reported. The significance of the arylation is highlighted by the new reactivity demonstrated in dioxazolones via proximal C-H activation of the cyclic carbonate of the hydroxamic acid functionality under protic conditions.
OXADIAZINE COMPOUNDS AND METHODS OF USE THEREOF
-
Paragraph 0252, (2016/12/26)
The present disclosure relates to oxadiazine compounds, pharmaceutical compositions comprising an effective amount of an oxadiazine compound and methods for using an oxadiazine compound in the treatment of a neurodegenerative disease, comprising administering to a subject in need thereof an effective amount of an oxadiazine compound.
